Tissue Microarray Technique in Evaluation of Proliferative Activity in Invasive Ductal Breast Cancer

被引:0
|
作者
Kobierzycki, Christopher [1 ]
Pula, Bartosz [1 ]
Wojnar, Andrzej [2 ]
Podhorska-Okolow, Marzena [1 ]
Dziegiel, Piotr [1 ,3 ,4 ]
机构
[1] Med Univ, Dept Histol & Embryol, PL-50368 Wroclaw, Poland
[2] Lower Silesian Oncol Ctr, Wroclaw, Poland
[3] Med Univ, Dept Histol & Embryol, Poznan, Poland
[4] Univ Wroclaw, Sch Phys Educ, Dept Physiotheraphy, Wroclaw, Poland
关键词
Tissue microarray; TMA; breast cancer; Ki-67; MCM-2; KI-67; ANTIGEN-EXPRESSION; NEEDLE-BIOPSY SPECIMENS; DNA-REPLICATION; MCM PROTEINS; PROGNOSTIC-SIGNIFICANCE; LUNG-CANCER; METALLOTHIONEIN; CELLS; BLOCK; VALIDATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Investigation of the relationship between expression of Ki-67 antigen and Minichromosome maintenance 2 (MCM-2) protein by using an immunohistochemical study on whole sections (WS) and sections of invasive ductal breast cancer (IDC) obtained in the tissue microarray (TMA) technique. Materials and Methods: Material consisted of 51 archival paraffin blocks of IDC. Tissue microarrays were composed of 0.6 mm core punches. Reactions were peformed using specific antibodies (anti-Ki-67 and anti-MCM-2). Intensity of the marker expression was evaluated using computer-assisted image analysis. For statistical purposes, three different tests were used. Results: Spearman rank correlation revealed a strong positive correlation between expression of tested markers: Ki-67 (TMA) vs. Ki-67 (WS) (r=0.91, p<0.05) and MCM-2 (TMA) vs. MCM-2 (WS) (r=0.87, p<0.05). Mann Whitney U-test showed no significant differences between the two markers in both analysed techniques. Moreover, the Bland-Altman plot demonstrated a low level of bias between the analysed methods. Conclusion: This study shows that TMA could have a great potential in evaluation of proliferative activity in IDC and that MCM-2 protein might he a specific and sensitive marker of cell proliferation.
引用
收藏
页码:773 / 777
页数:5
相关论文
共 50 条
  • [31] Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
    Fontein, D. B. Y.
    Engels, C. C.
    Bastiaannet, E.
    De Kruijf, E. M.
    Liefers, G. J.
    Nortier, J. W. R.
    Van de Velde, C. J. H.
    Kuppen, P. J. K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S150 - S150
  • [32] Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
    Engels, C. C.
    Fontein, D. B. Y.
    Kuppen, P. J. K.
    de Kruijf, E. M.
    Smit, V. T. H. B. M.
    Nortier, J. W. R.
    Liefers, G. J.
    van de Velde, C. J. H.
    Bastiaannet, E.
    BRITISH JOURNAL OF CANCER, 2014, 111 (03) : 532 - 538
  • [33] Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
    C C Engels
    D B Y Fontein
    P J K Kuppen
    E M de Kruijf
    V T H B M Smit
    J W R Nortier
    G J Liefers
    C J H van de Velde
    E Bastiaannet
    British Journal of Cancer, 2014, 111 : 532 - 538
  • [34] Tissue microarray technology in the routine assessment of HER2 status in invasive breast cancer
    Cryan, Jane
    O'Grady, Anthony
    Allen, David
    Kay, Elaine
    HISTOPATHOLOGY, 2009, 54 (07) : 901 - 901
  • [35] Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast
    Hasebe, T
    Sasaki, S
    Imoto, S
    Ochiai, A
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05): : 1701 - 1710
  • [36] Invasive ductal breast cancer metastatic to the sigmoid colon
    Zhou, Xiao-cong
    Zhou, Hong
    Ye, Ying-hai
    Zhang, Xiu-feng
    Jiang, Yi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [37] β-catenin gene mutation in invasive ductal breast cancer
    Kizildag, S.
    Zengel, B.
    Vardar, E.
    Sakizli, M.
    JOURNAL OF BUON, 2008, 13 (04): : 533 - 536
  • [38] CTCF Gene Mutations in Invasive Ductal Breast Cancer
    Sebastian Aulmann
    Hendrik Bläker
    Roland Penzel
    Ralf Joachim Rieker
    Herwart F. Otto
    Hans Peter Sinn
    Breast Cancer Research and Treatment, 2003, 80 : 347 - 352
  • [39] Is there 'progression through grade' in ductal invasive breast cancer?
    Schymik, Barbara
    Buerger, Horst
    Kraemer, Annika
    Voss, Ulli
    van der Groep, Petra
    Meinerz, Wolfgang
    van Diest, Paul J.
    Korsching, Eberhard
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 693 - 703
  • [40] Is there ‘progression through grade’ in ductal invasive breast cancer?
    Barbara Schymik
    Horst Buerger
    Annika Krämer
    Ulli Voss
    Petra van der Groep
    Wolfgang Meinerz
    Paul J. van Diest
    Eberhard Korsching
    Breast Cancer Research and Treatment, 2012, 135 : 693 - 703